Global Information
회사소개 | 문의 | 비교리스트

세계의 수두증 시장 예측

Global Hydrocephalus Market Research Report Forecast to 2023

리서치사 Market Research Future
발행일 2019년 04월 상품 코드 841554
페이지 정보 영문 139 Pages
가격
US $ 4,450 ₩ 5,288,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,427,000 Printable PDF (Corporate User License)


세계의 수두증 시장 예측 Global Hydrocephalus Market Research Report Forecast to 2023
발행일 : 2019년 04월 페이지 정보 : 영문 139 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 수두증(Hydrocephalus) 시장에 대해 조사 분석했으며, 시장 개요, 시장 동향, 시장 성장 촉진요인/억제요인, 종류별, 진단 방법별, 치료별, 최종사용자별, 지역별 시장 분석, 주요 기업 개요 등에 대해 정리했습니다.

제1장 보고서 서문

제2장 주요 요약

제3장 시장 서론

제4장 조사 방법

제5장 시장 역학

  • 서론
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
  • 세계적인 경제 상황의 변화

제6장 시장 요인 분석

  • Porter's Five Forces 모델
  • 밸류체인 분석
  • 투자 기회

제7장 세계의 수두증 시장 : 종류별

  • 서론
    • 선천성 수두증
    • 후천성 수두증
    • 정상압 수두증
    • 진공성 수두증

제8장 세계의 수두증 시장 : 진단 방법별

  • 서론
    • 두부 CT 스캔
    • MRI
    • 두부 초음파 검사

제9장 세계의 수두증 시장 : 치료별

  • 서론
    • 션트 수술
    • 뇌실조루술
    • 투약 치료

제10장 세계의 수두증 시장 : 최종사용자별

  • 서론
    • 병원/클리닉
    • 진단 센터
    • 학술기관/연구소

제11장 세계의 수두증 시장 : 지역별

  • 서론
  • 아메리카
  • 유럽
  • 서유럽
  • 아시아태평양
  • 중동 및 아프리카

제12장 경쟁 상황

  • 경쟁 시나리오
  • 기업의 시장 점유율 분석
  • 주요 발전

제13장 기업 개요

  • DePuy Synthes
  • Boston Neurosciences
  • Medtronic Plc
  • Integra LifeSciences Corporation
  • Spiegelberg GmbH & Co. KG
  • RAUMEDIC Inc.
  • Sophysa SA
  • Terumo Corporation
  • Natus Medical Incorporated
  • Johnson & Johnson Services Inc.
  • B. Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • Tokibo Co., Ltd.
  • HLL Lifecare Limited

제14장 부록

KSM 19.05.30

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 LIST OF ASSUMPTIONS
  • TABLE 3 GLOBAL HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL HYDROCEPHALUS MARKET FOR CONGENITAL HYDROCEPHALUS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL HYDROCEPHALUS MARKET FOR ACQUIRED HYDROCEPHALUS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL HYDROCEPHALUS MARKET FOR NORMAL-PRESSURE HYDROCEPHALUS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL HYDROCEPHALUS MARKET FOR EX-VACUO HYDROCEPHALUS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL HYDROCEPHALUS MARKET, FOR CT SCAN - HEAD BY REGION 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL HYDROCEPHALUS MARKET, FOR MRI BY REGION 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL HYDROCEPHALUS MARKET FOR HEAD ULTRASOUND, BY REGION 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL HYDROCEPHALUS MARKET, BY TREATMENT2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL HYDROCEPHALUS MARKET, FOR SURGERY - SHUNT INSERTION BY REGION, 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL HYDROCEPHALUS MARKET, FOR VENTRICULOSTOMY BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL HYDROCEPHALUS MARKET, FOR MEDICATION BY REGION, 2015-2023 (USD MILLION)
  • TABLE 17 GLOBAL HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 18 GLOBAL HYDROCEPHALUS MARKET FOR HOSPITALS & CLINICS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 19 GLOBAL HYDROCEPHALUS MARKET FOR DIAGNOSTIC CENTERS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 20 GLOBAL HYDROCEPHALUS MARKET FOR ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 21 GLOBAL HYDROCEPHALUS MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 22 AMERICAS HYDROCEPHALUS MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 23 AMERICAS HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 24 AMERICAS HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 25 AMERICAS HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 26 AMERICAS HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 AMERICAS HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 28 NORTH AMERICA HYDROCEPHALUS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 29 NORTH AMERICA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 30 NORTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 31 NORTH AMERICA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 32 NORTH AMERICA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 33 NORTH AMERICA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 34 US HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 35 US HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 36 US HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 37 US HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 38 US HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 39 CANADA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 40 CANADA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 41 CANADA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 42 CANADA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 43 CANADA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 44 SOUTH AMERICA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 45 SOUTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 46 SOUTH AMERICA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 47 SOUTH AMERICA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 48 SOUTH AMERICA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 49 EUROPE HYDROCEPHALUS MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 50 EUROPE HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 51 EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 52 EUROPE HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 53 EUROPE HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 54 EUROPE HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 55 WESTERN EUROPE HYDROCEPHALUS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 56 WESTERN EUROPE HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 57 WESTERN EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 58 WESTERN EUROPE HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 59 WESTERN EUROPE HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 60 WESTERN EUROPE HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 61 GERMANY HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 62 GERMANY HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 63 GERMANY HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 64 GERMANY HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 GERMANY HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 66 UK HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 67 UK HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 68 UK HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 69 UK HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 70 UK HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 71 FRANCE HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 72 FRANCE HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 73 FRANCE HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 74 FRANCE HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 75 FRANCE HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 76 SPAIN HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 77 SPAIN HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 78 SPAIN HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 79 SPAIN HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 80 SPAIN HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 81 ITALY HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 82 ITALY HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 83 ITALY HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 84 ITALY HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 85 ITALY HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 86 . REST OF WESTERN EUROPE HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 87 REST OF WESTERN EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 88 REST OF WESTERN EUROPE HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 89 REST OF WESTERN EUROPE HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 REST OF WESTERN EUROPE HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 91 EASTERN EUROPE HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 92 EASTERN EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 93 EASTERN EUROPE HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 94 EASTERN EUROPE HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 95 EASTERN EUROPE HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 96 ASIA PACFIC HYDROCEPHALUS MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 97 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 98 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 99 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 100 ASIA-PACIFIC HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 101 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 102 CHINA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 103 CHINA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 104 CHINA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 105 CHINA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 106 CHINA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 107 JAPAN HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 108 JAPAN HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 109 JAPAN HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 110 JAPAN HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 JAPAN HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 112 INDIA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 113 INDIA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 114 INDIA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 115 INDIA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 116 INDIA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 117 AUSTRALIA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 118 AUSTRALIA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 119 AUSTRALIA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 120 AUSTRALIA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 121 AUSTRALIA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 122 SOUTH KOREA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 123 SOUTH KOREA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 124 SOUTH KOREA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 125 SOUTH KOREA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 126 SOUTH KOREA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 127 REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 128 REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 129 REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 130 REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 131 REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA HYDROCEPHALUS MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA MERICAS HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 134 MIDDLE EAST & AFRICA MERICAS HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 135 MIDDLE EAST & AFRICA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 136 MIDDLE EAST & AFRICA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 137 MIDDLE EAST & AFRICA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 138 MIDDLE EAST HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 139 MIDDLE EAST HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 140 MIDDLE EAST HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 141 MIDDLE EAST HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 142 MIDDLE EAST HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 143 AFRICA HYDROCEPHALUS MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 144 AFRICA HYDROCEPHALUS MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
  • TABLE 145 AFRICA HYDROCEPHALUS MARKET, BY TREATMENT 2015-2023 (USD MILLION)
  • TABLE 146 AFRICA HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 147 AFRICA HYDROCEPHALUS MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 148 GLOBAL HYDROCEPHALUS MARKET: KEY DEVELOPMENT

List of Figures

  • FIGURE 1 GLOBAL HYDROCEPHALUS MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS OF MRFR
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HYDROCEPHALUS MARKET
  • FIGURE 5 VALUE CHAIN: GLOBAL HYDROCEPHALUS MARKET
  • FIGURE 6 GLOBAL HYDROCEPHALUS MARKET, BY TYPE 2017 & 2023 (USD MILLION)
  • FIGURE 7 GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSIS 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL HYDROCEPHALUS MARKET, BY TREATMENT 2017 & 2023 (USD MILLION)
  • FIGURE 9 GLOBAL HYDROCEPHALUS MARKET, BY END USER 2017 & 2023 (USD MILLION)
  • FIGURE 10 GLOBAL HYDROCEPHALUS MARKET, BY REGION 2017 & 2023 (USD MILLION)
  • FIGURE 11 AMERICAS HYDROCEPHALUS MARKET, BY REGION COUNTRY 2017 (%)
  • FIGURE 12 NORTH AMERICA HYDROCEPHALUS MARKET, BY COUNTRY 2017 (%)
  • FIGURE 13 EUROPE HYDROCEPHALUS MARKET, BY REGION 2017 (%)
  • FIGURE 14 WESTERN EUROPE HYDROCEPHALUS MARKET, BY COUNTRY 2017 (%)
  • FIGURE 15 ASIA PACFIC HYDROCEPHALUS MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)
  • FIGURE 16 MIDDLE EAST & AFRICA HYDROCEPHALUS MARKET, BY COUNTRY 2017 (%)
  • FIGURE 17 GLOBAL HYDROCEPHALUS MARKET COMPETITIVE LANDSCAPE (%)
  • FIGURE 18 GLOBAL HYDROCEPHALUS MARKET, MARKET SHARE ANALYSIS 2017 (%)

Hydrocephalus Market Research Report: by Type (Normal-pressure Hydrocephalus, Congenital Hydrocephalus, Acquired Hydrocephalus, Ex-vacuo Hydrocephalus), by Diagnosis (MRI, Head Ultrasound, CT Scan - Head, Others), by Treatment (Medication, Ventriculostomy, Surgery - Shunt Insertion, Others), by End-user (Hospitals & Clinics, Academic Institutions & Research Centers, Diagnostic Centers, Others), and Region - Global Forecast till 2023

Market analysis

Hydrocephalus is an ailment in which the abundance aggregation of cerebrospinal liquid (CSF) in the ventricles may prompt a few neurological deficiencies. This condition is generally seen in kids in which the fetus is malnourished. The expanding pervasiveness of traumatic brain injuries (TBI) is the essential driver of the market. Nonstop advancement of shunts by producers which can aid seepage of CSF is touted to goad the hydrocephalus market development till 2023. Rising instances of neurological conditions, for example, cerebrum aneurysm and others can support advertise request. Furthermore, the presentation of repayment plans which spread treatment for hydrocephalus can work for the market until the finish of the conjecture time frame. The global hydrocephalus market is anticipated to reach a valuation of USD 1,752.07 million by the year 2023 growing at 4.4% CAGR during the forecast period (2018-2023).

Market segmentation '

Based on its type, the global hydrocephalus market is segmented into acquired, congenital, normal-pressure, and ex-vacuo hydrocephalus. On the basis of its methods, the market includes head ultrasound, magnetic resonance imaging (MRI), and CT scan - head. Based on its treatment options, the market includes medication, surgery - shunt insertion, ventriculostomy. By end-user, the hydrocephalus market is bifurcated into academic institutions & research centers, hospitals & clinics, and diagnostic centers.

Regional analysis

Geographically, the global hydrocephalus market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Natus Medical Incorporated (U.S.), Johnson & Johnson Services Inc. (U.S.), B. Braun Melsungen AG (Germany), Christoph Miethke GmbH & Co. KG (Germany), Tokibo Co., Ltd. (Japan), and HLL Lifecare Limited (India), Integra LifeSciences Corporation (U.S.), Spiegelberg GmbH & Co. KG (Germany), RAUMEDIC Inc. (Germany), Sophysa SA (France), Terumo Corporation (U.S.), among others are some of the major players in the global hydrocephalus market.

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

  • 3.1 Scope of Study
  • 3.2 Research Objective
  • 3.3 List of Assumptions
  • 3.4 Market Structure

4 Research Methodology

  • 4.1 Research Process
  • 4.2 Primary Research
  • 4.3 Secondary Research
  • 4.4 Market Size Estimation
  • 4.5 Forecast Model

5 Market Dynamics

  • 5.1 Introduction
  • 5.2 Drivers
    • 5.2.1 Growing prevalence of traumatic brain injuries
    • 5.2.2 Ongoing product development & commercialization will boost the adoption of hydrocephalus shunts in the market
    • 5.2.3 Favorable reimbursement policies provide favorable background for the market growth
    • 5.2.4 Increasing prevalence of neurovascular diseases such as brain aneurysm, Arteriovenous Malformations (AVMs), and others, are likely to propel the hydrocephalus market
  • 5.3 Restraints
    • 5.3.1 High procedural cost of ICP monitoring devices
    • 5.3.2 Shortage of trained professionals
  • 5.4 Opportunities
    • 5.4.1 Increase in awareness of intraoperative neurophysiological monitoring (IONM)
    • 5.4.2 Increasing use of endovascular embolization for the treatment of brain aneurysm
    • 5.4.3 Technological advancements in over the wire micro guide catheters
  • 5.5 Challenges
    • 5.5.1 Rising partnership among competitors leading to rivalry
  • 5.6 Changing economic conditions globally

6 Market Factor Analysis

  • 6.1 Porter's Five Forces Model
    • 6.1.1 Bargaining Power of Suppliers
    • 6.1.2 Bargaining Power of Buyers
    • 6.1.3 Threat of New Entrants
    • 6.1.4 Threat of Substitutes
    • 6.1.5 Intense Rivalry
  • 6.2 Value chain analysis
    • 6.2.1 R&D
    • 6.2.2 Manufacturing
    • 6.2.3 Distribution & Sales
    • 6.2.4 Post-Sales Monitoring
  • 6.3 Investment Opportunities

7 Global Hydrocephalus Market, By Type

  • 7.1 Introduction
    • 7.1.1 Congenital hydrocephalus
    • 7.1.2 Acquired hydrocephalus
    • 7.1.3 Normal-pressure hydrocephalus
    • 7.1.4 Ex-vacuo hydrocephalus

8 Global Hydrocephalus Market, By Diagnosis

  • 8.1 Introduction
    • 8.1.1 CT scan - head
    • 8.1.2 MRI
    • 8.1.3 Head Ultrasound

9 Global Hydrocephalus Market, By Treatment

  • 9.1 Introduction
    • 9.1.1 Surgery - Shunt Insertion
    • 9.1.2 Ventriculostomy
    • 9.1.3 Medication

10 Global Hydrocephalus Market, By End User

  • 10.1 Introduction
    • 10.1.1 Hospitals & Clinics
    • 10.1.2 Diagnostic Centres
    • 10.1.3 Academic Institutions and Research Organizations

11 Global Hydrocephalus Market, By Region

  • 11.1 Introduction
  • 11.2 Americas
    • 11.2.1 North America
      • 11.2.1.1 US
      • 11.2.1.2 Canada
    • 11.2.2 South America
  • 11.3 Europe
  • 11.4 Western Europe
    • 11.4.1 Germany
    • 11.4.2 UK
    • 11.4.3 France
    • 11.4.4 Spain
    • 11.4.5 Italy
    • 11.4.6 Rest of Western Europe
    • 11.4.7 Eastern Europe
  • 11.5 Asia-Pacific
    • 11.5.1 China
    • 11.5.2 Japan
    • 11.5.3 India
    • 11.5.4 Australia
    • 11.5.5 South Korea
    • 11.5.6 Rest of Asia-Pacific
  • 11.6 Middle East & Africa
    • 11.6.1 Middle East
    • 11.6.2 Africa

12 Competitive Landscape

  • 12.1 Competitive Scenario
    • 12.1.1 Introduction
  • 12.2 Company Market Share Analysis
    • 12.2.1 Introduction
  • 12.3 Key Developments

13 Company Profiles

  • 13.1 DePuy Synthes
    • 13.1.1 Company Overview
    • 13.1.2 Financial Overview
    • 13.1.3 Products Offering
    • 13.1.4 Key Developments
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Strategy
  • 13.2 Boston Neurosciences
    • 13.2.1 Company Overview
    • 13.2.2 Financial Overview
    • 13.2.3 Products Offering
    • 13.2.4 Key Developments
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Strategy
  • 13.3 Medtronic Plc
    • 13.3.1 Company Overview
    • 13.3.2 Financial Overview
    • 13.3.3 Products Offering
    • 13.3.4 Key Developments
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Strategy
  • 13.4 Integra LifeSciences Corporation
    • 13.4.1 Company Overview
    • 13.4.2 Financial Overview
    • 13.4.3 Products Offering
    • 13.4.4 Key Developments
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Strategy
  • 13.5 Spiegelberg GmbH & Co. KG
    • 13.5.1 Company Overview
    • 13.5.2 Financial Overview
    • 13.5.3 Products Offering
    • 13.5.4 Key Developments
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Strategy
  • 13.6 RAUMEDIC Inc.
    • 13.6.1 Company Overview
    • 13.6.2 Financial Overview
    • 13.6.3 Products Offering
    • 13.6.4 Key Developments
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Strategy
  • 13.7 Sophysa SA
    • 13.7.1 Company Overview
    • 13.7.2 Financial Overview
    • 13.7.3 Products Offering
    • 13.7.4 Key Developments
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Strategy
  • 13.8 Terumo Corporation
    • 13.8.1 Company Overview
    • 13.8.2 Financial Overview
    • 13.8.3 Products Offering
    • 13.8.4 Key Developments
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Strategy
  • 13.9 Natus Medical Incorporated
    • 13.9.1 Company Overview
    • 13.9.2 Financial Overview
    • 13.9.3 Products Offering
    • 13.9.4 Key Developments
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Strategy
  • 13.1 Johnson & Johnson Services Inc.
    • 13.10.1 Company Overview
    • 13.10.2 Financial Overview
    • 13.10.3 Products Offering
    • 13.10.4 Key Developments
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Strategy
  • 13.11 B. Braun Melsungen AG
    • 13.11.1 Company Overview
    • 13.11.2 Financial Overview
    • 13.11.3 1.10.3 Products Offering
    • 13.11.4 Key Developments
    • 13.11.5 SWOT Analysis
    • 13.11.6 1.10.6 Key Strategy
  • 13.12 Christoph Miethke GmbH & Co. KG
    • 13.12.1 Company Overview
    • 13.12.2 Financial Overview
    • 13.12.3 Products Offering
    • 13.12.4 Key Developments
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Strategy
  • 13.13 Tokibo Co., Ltd.
    • 13.13.1 Company Overview
    • 13.13.2 Financial Overview
    • 13.13.3 Products Offering
    • 13.13.4 Key Developments
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Strategy
  • 13.14 HLL Lifecare Limited
    • 13.14.1 Company Overview
    • 13.14.2 Financial Overview
    • 13.14.3 Products Offering
    • 13.14.4 Key Developments
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Strategy

14 Appendix

  • 14.1 Discussion Blue Print
Back to Top
전화 문의
F A Q